Severe and active atopic eczema in adulthood is associated with an increased risk for developing cardiovascular disease (CVD), including stroke, heart failure, myocardial infarction (MI) and atrial fibrillation (AFib), according to a new study published May 23 in The BMJ.

A higher testosterone-to-estrogen ratio could be a harbinger of future cardiovascular disease (CVD) among post-menopausal women, according to a study published May 28 in the Journal of the American College of Cardiology.

Several models have been developed to predict mortality among heart failure patients, but clinicians remain reluctant to use them in everyday practice. In fact, fewer than 1 percent of patients received a prognostic estimate from their physicians in a European registry analysis published in JACC: Heart Failure.

Human growth hormone showed the potential to improve the memory and cognitive function of mice post-stroke, raising the possibility of a similar treatment for humans.

Hypertensive patients collect $1,920 more in annual healthcare expenditures compared to healthy individuals, according to a study published in the Journal of the American Heart Association on May 30.

WAYNE, N.J., May 25, 2018 — Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP Implantation (SEMPER FI) pilot study.

Patients who required permanent pacemakers (PPMs) after transcatheter aortic valve replacement (TAVR) demonstrated lower survival rates and higher comorbidity burdens over a multiyear follow-up. However, they didn’t accumulate significantly greater healthcare costs, according to a study published online May 25 in JAMA Network Open.

At just 5-months-old, Luke Pilkinton has survived what most would hope never to experience in a lifetime. He was born with hypoplastic left heart syndrome—a rare and deadly congenital defect, that affects 960 babies born in the U.S. every year.